Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

275 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Questionnaire survey of the views of the delegates at the European Cervical Spine Research Society meeting on the administration of methylprednisolone for acute traumatic spinal cord injury.
Molloy S, Price M, Casey AT. Molloy S, et al. Spine (Phila Pa 1976). 2001 Dec 15;26(24):E562-4. doi: 10.1097/00007632-200112150-00017. Spine (Phila Pa 1976). 2001. PMID: 11740372
Levodopa use and sleep in patients with dementia with Lewy bodies.
Molloy S, Minett T, O'Brien JT, McKeith IG, Burn DJ. Molloy S, et al. Mov Disord. 2009 Mar 15;24(4):609-12. doi: 10.1002/mds.22411. Mov Disord. 2009. PMID: 19191343 Clinical Trial.
Sleep disturbance and excessive daytime somnolence (EDS) are features of Parkinson's disease (PD) and dementia with Lewy bodies (DLB) that may be influenced by dopamine replacement therapy. ...Dopamine naïve patients with DLB (n = 15; mean mini mental state examination (MM …
Sleep disturbance and excessive daytime somnolence (EDS) are features of Parkinson's disease (PD) and dementia with Lewy bodies (DLB) …
Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients.
Politis M, Wu K, Loane C, Brooks DJ, Kiferle L, Turkheimer FE, Bain P, Molloy S, Piccini P. Politis M, et al. J Clin Invest. 2014 Mar;124(3):1340-9. doi: 10.1172/JCI71640. Epub 2014 Feb 17. J Clin Invest. 2014. PMID: 24531549 Free PMC article. Clinical Trial.
Levodopa-induced dyskinesias (LIDs) are the most common and disabling adverse motor effect of therapy in Parkinson's disease (PD) patients. ...
Levodopa-induced dyskinesias (LIDs) are the most common and disabling adverse motor effect of therapy in Parkinson's disease (PD) pat …
Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease.
Pagano G, Molloy S, Bain PG, Rabiner EA, Chaudhuri KR, Brooks DJ, Pavese N. Pagano G, et al. Neurology. 2016 Dec 6;87(23):2451-2456. doi: 10.1212/WNL.0000000000003396. Epub 2016 Nov 2. Neurology. 2016. PMID: 27807182 Free PMC article.
Severity of sleep problems was rated with appropriate subitems of the Unified Parkinson's Disease Rating Scale part I (patient questionnaire) and the Epworth Sleepiness Scale. ...
Severity of sleep problems was rated with appropriate subitems of the Unified Parkinson's Disease Rating Scale part I (patient questi …
Parkinson's disease symptoms: the patient's perspective.
Politis M, Wu K, Molloy S, G Bain P, Chaudhuri KR, Piccini P. Politis M, et al. Mov Disord. 2010 Aug 15;25(11):1646-51. doi: 10.1002/mds.23135. Mov Disord. 2010. PMID: 20629164
Patients suffering from Parkinson's disease (PD) will typically experience a range of motor and nonmotor symptoms during the course of their illness, each of which will affect a particular individual to varying degrees. However, patients' perceptions of troublesome symptom …
Patients suffering from Parkinson's disease (PD) will typically experience a range of motor and nonmotor symptoms during the course o …
Longitudinal change in 99mTcHMPAO cerebral perfusion SPECT in Parkinson's disease over one year.
Firbank MJ, Molloy S, McKeith IG, Burn DJ, O'Brien JT. Firbank MJ, et al. J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1448-51. doi: 10.1136/jnnp.2004.058685. J Neurol Neurosurg Psychiatry. 2005. PMID: 16170094 Free PMC article.
BACKGROUND: Brain perfusion deficits have been reported previously in subjects with Parkinson's disease in comparison with healthy controls. ...CONCLUSIONS: The progressive frontal perfusion deficits in Parkinson's disease are consistent with results from previous s …
BACKGROUND: Brain perfusion deficits have been reported previously in subjects with Parkinson's disease in comparison with healthy co …
Reversible delayed posthypoxic leukoencephalopathy.
Molloy S, Soh C, Williams TL. Molloy S, et al. AJNR Am J Neuroradiol. 2006 Sep;27(8):1763-5. AJNR Am J Neuroradiol. 2006. PMID: 16971632
Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study.
Politis M, Wu K, Loane C, Kiferle L, Molloy S, Brooks DJ, Piccini P. Politis M, et al. Neurobiol Dis. 2010 Oct;40(1):216-21. doi: 10.1016/j.nbd.2010.05.028. Epub 2010 May 31. Neurobiol Dis. 2010. PMID: 20594979
Thirty Parkinson's disease (PD) patients were divided into three equal groups according to their disease duration while 10 normal healthy volunteers matched for age and sex served as a control group. ...
Thirty Parkinson's disease (PD) patients were divided into three equal groups according to their disease duration while 10 normal hea …
Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies.
Burn DJ, Rowan EN, Allan LM, Molloy S, O'Brien JT, McKeith IG. Burn DJ, et al. J Neurol Neurosurg Psychiatry. 2006 May;77(5):585-9. doi: 10.1136/jnnp.2005.081711. J Neurol Neurosurg Psychiatry. 2006. PMID: 16614017 Free PMC article.
BACKGROUND: A previous cross sectional study found over-representation of a postural instability gait difficulty (PIGD) motor subtype in Parkinson's disease patients with dementia (PDD) and dementia with Lewy bodies (DLB), compared with Parkinson's disease (PD). ... …
BACKGROUND: A previous cross sectional study found over-representation of a postural instability gait difficulty (PIGD) motor subtype in Par …
275 results
Jump to page
Feedback